Hexagon Nutrition544785Earnings call transcript
Q2 & H1 FY27 call: revenue up 27.3% to INR214 crores, Q2 gross margin 47%, inventory built for H2 orders
Hexagon Nutrition has shared the transcript of its Q2 & H1 FY27 earnings call held on November 17, 2026.
By ScoutQuest · · 3 min read
- H1 revenue from operations
- INR214 crores, up 27.3% year-on-year
- Q2 revenue from operations
- INR109.7 crores, up 15.2%
- Q2 gross margin
- 47%, up about 310 basis points from 43.9% in Q1, but below 53.1% a year ago
Revenue growth
- For the half year, revenue from operations was INR214 crores, up 27.3% from INR168 crores in the same period last year.
- For the second quarter, revenue from operations was INR109.7 crores, up 15.2% over the same quarter last year and 5.1% over the first quarter.
- Management said the growth came from a rise in sales volume and value in both the branded and the premix businesses.
Margins
- Q2 gross margin was 47%, an improvement of about 310 basis points over 43.9% in Q1, against 53.1% in the second quarter last year.
- Q2 EBITDA was INR10.9 crores, including an exceptional loss of INR1.1 crores on disposal of older plant and equipment. Before this item, EBITDA was INR12 crores, a margin of 10.9%.
- Q2 profit before tax was INR10.1 crores and profit after tax INR8.2 crores, up 1% from the first quarter.
- H1 EBITDA was INR22.7 crores, or INR23.7 crores before the exceptional item, a margin of 10.6% and 11.1% respectively.
- H1 profit before tax was INR20.8 crores and profit after tax INR16.2 crores, compared with INR15.6 crores last year. Basic earnings per share was INR1.41.
- Employee cost was 14.7% of revenue, up from 13.3%, reflecting investment in the field force and in R&D, quality, sales and compliance capability.
Three-part margin plan outlined
- Pricing: price increases taken on branded products, with the benefit expected over the next 1 to 2 quarters.
- Procurement: longer contracts negotiated and supply of key raw materials secured.
- Mix: focus on higher margin products and customers, supported by R&D work on low-cost formulations.
Balance sheet and cash
- Total equity at September 30 was INR245 crores; equity instruments of about INR12 crores were converted into equity shares, taking share capital to INR12.3 crores.
- Inventory rose to INR136 crores from INR84 crores in March, mainly to secure raw material supply ahead of confirmed second-half orders.
- Operating cash flow was negative INR8.6 crores for the half year, mainly due to the inventory build. Operating profit before working capital changes was INR26.4 crores after tax paid of INR8.4 crore.
- Cash, bank deposits and liquid funds stood at INR46.5 crores against total borrowings of INR37.4 crores, leaving the company net cash positive by around INR9 crores, with a debt-to-equity ratio of about 0.15.
- Receivables improved to INR77 crores from INR82 crores; trade payables rose to about INR47 crores.
- Capital expenditure in the half was INR4 crores and dividend paid was INR3.7 crores.
What management guided for
- Second-half revenue momentum is expected to continue, driven by the field force for the branded business and a strong order book in the premix and ESG business.
- Margins are expected to improve progressively as the pricing and procurement actions take effect.
- Inventory is expected to return to normal levels by March 2027 as it converts into sales and cash.
- The company will continue its capex plan for modification of the Nashik Premix Facility, with major funding from a bank loan of about INR 20 Crore. Reconstruction work at the Nashik facility has been initiated.
- First-half capacity utilisation was around 30%, and the company has collaborated with Particles for Humanity on new product development for a stable form of Vitamin A+.
Also from Hexagon Nutrition
Hexagon Nutrition files audio recording of Q2 & H1 FY27 earnings conference call held November 17, 2026
17 Nov 2026
Hexagon Nutrition Q2 FY27 investor presentation: revenue up 15.2%, profit and margins decline
17 Nov 2026
Hexagon Nutrition Q2 FY27: consolidated revenue up 15.2%, EBITDA down 11.3%, PAT down 19.6%
16 Nov 2026
More numbers
- H1 FY27 revenue from operationsINR214 crores
- Q2 FY27 revenue from operationsINR109.7 crores
- Q2 FY27 gross margin47%
- H1 FY27 EBITDAINR22.7 crores
- H1 FY27 profit after taxINR16.2 crores
- Inventory at September 30INR136 crores
- Operating cash flow for the half yearnegative INR8.6 crores
- H1 FY27 revenue growth27.3%
Source: BSE · 21 Nov 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.